Xylocaine in the therapy of arrhythmia
Lapińska, K.; Poplawska, W.
Kardiologia Polska 13(1): 103-106
1970
ISSN/ISBN: 0022-9032 PMID: 5423404 Document Number: 28141
Document emailed within 1 workday
Related Documents
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90Schollmeyer, P. 1973: Arrhythmia following drug therapy Die Medizinische Welt 24(26): 1092-1096
So, C.S. 1979: Arrhythmia. Diagnosis and therapy Medizinische Klinik 74(32-33): Preceding 1189
So, C.S. 1979: Arrhythmia. Diagnosis and therapy. Pacemaker ECG Ii Medizinische Klinik 74(31): Preceding 1159
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Yazaki, Y.; Ohta, A.; Tsunakawa, H.; Harumi, K. 1984: Diagnosis of arrhythmia. a. Invasive arrhythmia analysis and provocation tests Nihon Rinsho. Japanese Journal of Clinical Medicine 42(12): 2676-2686
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Toivonen, L.; Heikkilä, J. 1986: Drug therapy of arrhythmia--ECG, a "cosmetic" or benefit to the patient? Duodecim; Laaketieteellinen Aikakauskirja 102(22): 1651-1661
Kowalski, E.; Pronicki, B.; Salyk, A.; Mrozowski, J.; Rakowska-Wódz, B. 1976: Hyaluronidase and xylocaine in cervical dystoncia Wiadomosci Lekarskie 29(17): 1521-1525
Geibel, A.; Zehender, M.; Hohnloser, S.; Landsrath, C.; Meinertz, T.; Just, H. 1988: Diprafenone--comparative study of anti-arrhythmia therapy with propafenone Zeitschrift für Kardiologie 77(7): 464-469
So, C.S. 1978: Arrhythmia. Diagnosis and therapy. WPW (Wolff-Parkinson-White)syndrome i Medizinische Klinik 73(49): Preceding 1731
Critelli, G. 1993: Transcatheter ablation: a turning point in anti-arrhythmia therapy Cardiologia 38(10): 661-667
Follath, F.; Candinas, R.; Frielingsdorf, J. 1993: Therapy of atrial fibrillation with class III anti-arrhythmia agents Herz 18(1): 20-26
Handa, S.; Mitamura, H. 1980: Arrhythmia and differential diagnosis: supraventricular arrhythmia Nursing Technique 26(2): 166-172
Sulimov, V.A. 1999: "Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture] Terapevticheskii Arkhiv 71(8): 67-74